# BORTEZOMIB

NDC: 55150-337
Generic name: BORTEZOMIB
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20220502

FDA application: ANDA212825

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-337"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-337
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76c7c3a5-fd2f-403f-85fd-65a64538eee7